Clinical Trials

170 enrolled

Esophageal Achalasia, Esophageal Diseases, Esophageal Motility Disorders, Gastroparesis

NCT07429643 2026-02-24

Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.

20 enrolled

Locally Advanced Pancreatic Cancer

NCT03051464 2026-02-17

Morpheus

131 enrolled

Rectal Neoplasms

NCT07044453 2026-02-17

PANACHE 02

390 enrolled

Resected Pancreatic Adenocarcinoma

NCT07392866 2026-02-09

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

120 enrolled

Carcinoma, Hepatocellular

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Phase 2/3 Completed

124 enrolled

Colorectal Neoplasms

NCT04749108 2026-02-05

GRECCAR14

1,075 enrolled

Rectal Neoplasms

NCT06904170 2026-02-03

ALICE

196 enrolled

Carcinoma, Hepatocellular

NCT07379047 2026-01-30

GISTAR-1

255 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04137107 2026-01-26

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

220 enrolled

Colorectal Neoplasms

NCT05710406 2026-01-26

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

1 enrolled

Colonic Neoplasms

NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Phase 2/3 Completed

124 enrolled

Liver Neoplasms, Pain, Postoperative

NCT06312982 2026-01-13

A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer

375 enrolled

Locally Advanced Rectal Carcinoma

NCT07332533 2026-01-12

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

490 enrolled

HER2-positive Gastric Cancer

NCT06115499 2026-01-07

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT07321847 2026-01-07

INJECTABL-3

717 enrolled

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05215379 2026-01-02

Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer

Phase 2/3 Completed

201 enrolled

Rectal Neoplasms

NCT04353375 2025-12-31

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

GastrointestinalOther solid neoplasm

235 enrolled

Advanced Intrahepatic Cholangiocarcinoma

NCT06361888 2025-12-30

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

502 enrolled

Pancreatic Neoplasms

NCT07309419 2025-12-30

Cocktail-001

222 enrolled

Carcinoma, Hepatocellular

NCT05171166 2025-12-18

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Phase 2/3 Terminated

18 enrolled

Carcinoma, Hepatocellular

NCT05902533 2025-12-18

REDEL

33 enrolled

Anus Neoplasms

NCT07285850 2025-12-16

ABATE-MASLD

20 enrolled

Carcinoma, Hepatocellular

NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

100 enrolled

Colonic Neoplasms

NCT06851663 2025-12-08

Trop2-targeted immunoPET Imaging of Solid Tumors

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

400 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06783140 2025-12-05

PLATINUM-CAN

10 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT05786716 2025-12-02

DETERMINE

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

30 enrolled

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT07251062 2025-11-26

A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

737 enrolled